Stableford Capital II’s Boston Scientific BSX Stock Holding History

Stableford Capital II’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,679	Closed	-$545K	–	149
2026 Q1	$545K	Sell	8,679 -64	-0.7%	-$5.12K	0.2%	119
2025 Q4	$834K	Sell	8,743 -424	-5%	-$41.6K	0.3%	107
2025 Q3	$895K	Buy	9,167 +27	+0.3%	+$2.8K	0.32%	100
2025 Q2	$970K	Sell	9,140 -136	-1%	-$13.8K	0.37%	83
2025 Q1	$882K	Sell	9,276 -3	-0%	-$302	0.37%	69
2024 Q4	$829K	Buy	+9,279	New	+$817K	0.33%	95
2022 Q2	–	Sell	-20,702	Closed	-$931K	–	120
2022 Q1	$931K	Buy	+20,702	New	+$897K	0.39%	63

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Stableford Capital II's BSX Position: Q2 2026 in Review

Stableford Capital II sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 8,679 shares — an estimated $545K sold.

Stableford Capital II first reported a position in BSX in Q1 2022 and held it in 7 quarters. The position peaked at $970K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Stableford Capital II reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Stableford Capital II sold 8,679 Boston Scientific shares in Q2 2026, an estimated $545K.
Stableford Capital II first reported a position in Boston Scientific in Q1 2022 and held it in 7 quarters.
Stableford Capital II's Boston Scientific position peaked at $970K in Q2 2025.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Stableford Capital II's 13F filing for Q2 2026, filed 6 Jul 2026.